Profil
Ian A. Critchley was Executive Director-Microbiology at Replidyne, Inc. from 2002 to 2008.
From 2008 to 2014, served as Vice President-Clinical Microbiology at Cerexa, Inc. Between 2015 and 2018, held the position of Vice President-Clinical Microbiology at Allergan UC.
Currently holds the title of Vice President-Clinical Microbiology at Spero Therapeutics, Inc. Education includes a doctorate from the University of Glasgow.
Anciens postes connus de Ian Critchley
| Sociétés | Poste | Fin |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/03/2026 |
| ALLERGAN PLC | Corporate Officer/Principal | 01/04/2018 |
Cerexa, Inc.
Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Corporate Officer/Principal | 01/12/2014 |
Replidyne, Inc.
Replidyne, Inc. BiotechnologyHealth Technology Develops and commercializes novel antibiotics to treat infections caused by drug resistant bacteria | Corporate Officer/Principal | 01/06/2008 |
Formation de Ian Critchley
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Replidyne, Inc.
Replidyne, Inc. BiotechnologyHealth Technology Develops and commercializes novel antibiotics to treat infections caused by drug resistant bacteria | Health Technology |
Cerexa, Inc.
Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
University of Glasgow
University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
Spero Therapeutics, Inc.
Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
















